Catherine Novack
Stock Analyst at Jones Trading
(2.18)
# 2,850
Out of 5,138 analysts
23
Total ratings
31.58%
Success rate
4.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SEPN Septerna | Initiates: Buy | $43 | $27.01 | +59.23% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $8.52 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $15.52 | +112.63% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $16.58 | +80.94% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $24.20 | +19.83% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.68 | +784.04% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.62 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $98.01 | -54.09% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.68 | +554.76% | 1 | Feb 12, 2025 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.15 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $13.82 | +15.77% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.20 | +337.50% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.96 | +563.27% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.89 | +246.02% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $5.60 | +292.86% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.15 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.61 | +26,333.17% | 1 | Jul 21, 2023 |
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $27.01
Upside: +59.23%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.52
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $15.52
Upside: +112.63%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $16.58
Upside: +80.94%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $24.20
Upside: +19.83%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.68
Upside: +784.04%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.62
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $98.01
Upside: -54.09%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.68
Upside: +554.76%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.15
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $13.82
Upside: +15.77%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.20
Upside: +337.50%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.96
Upside: +563.27%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $2.89
Upside: +246.02%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $5.60
Upside: +292.86%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.15
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.61
Upside: +26,333.17%